
Brite Health provides AI-driven tools to accelerate drug development and improve clinical trial design. The platform applies machine learning models and data analytics to inform trial planning, patient selection, and outcome prediction. It is positioned as a B2B SaaS solution serving pharmaceutical companies, biotech firms, and clinical research organizations. The company's core technologies include artificial intelligence and predictive analytics tailored for drug development workflows. Brite Health targets the clinical trials market to reduce time and risk across development programs.

Brite Health provides AI-driven tools to accelerate drug development and improve clinical trial design. The platform applies machine learning models and data analytics to inform trial planning, patient selection, and outcome prediction. It is positioned as a B2B SaaS solution serving pharmaceutical companies, biotech firms, and clinical research organizations. The company's core technologies include artificial intelligence and predictive analytics tailored for drug development workflows. Brite Health targets the clinical trials market to reduce time and risk across development programs.
What they do: AI platform for drug development and clinical-trial support (trial design, patient selection, outcome prediction).
Founded / HQ: Founded 2015; based in the San Francisco Bay Area (Palo Alto / Mountain View).
Founders: Niousha Zadeh; Sanaz Motahari; Alireza Forouzan.
Investors: Seed-stage backers include Stanford Angels & Entrepreneurs, Unshackled Ventures, and SAP.iO.
Funding notes: $25,000 reported accelerator/incubator funding (June 2016); other seed-round details largely undisclosed.
Drug development and clinical trials (design, patient recruitment/selection, outcome prediction).
2015
Biotechnology
$25,000
Reported accelerator/incubator funding.
Seed-round lead investor listed; amount undisclosed in available records.
Multiple funding rounds recorded; additional details not publicly disclosed in available sources.
“Has received seed-stage backing from Stanford Angels & Entrepreneurs, Unshackled Ventures, and SAP.iO.”